We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMO
1376
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-6,754
Closed -$85K
SNDX icon
1377
Syndax Pharmaceuticals
SNDX
$1.84B
-3,402
Closed -$76K
SPRO icon
1378
Spero Therapeutics
SPRO
$68.9M
-1,608
Closed -$24K
SPTN
1379
DELISTED
SpartanNash
SPTN
-124,759
Closed -$2.45M
SRPT icon
1380
Sarepta Therapeutics
SRPT
$1.66B
-895
Closed -$67K
SRRK icon
1381
Scholar Rock
SRRK
$5.71B
-1,138
Closed -$58K
STOK icon
1382
Stoke Therapeutics
STOK
$1.82B
-811
Closed -$31K
STRO icon
1383
Sutro Biopharma
STRO
$379M
-322
Closed -$73K
STTK icon
1384
Shattuck Labs
STTK
$710M
-870
Closed -$25K
SVC
1385
Service Properties Trust
SVC
$1.1B
-3,515
Closed -$208K
SWTX
1386
DELISTED
SpringWorks Therapeutics
SWTX
-988
Closed -$73K
TCRT icon
1387
Alaunos Therapeutics
TCRT
$4.74M
-84
Closed -$45K
TG icon
1388
Tredegar Corp
TG
$268M
-44,318
Closed -$665K
TGTX icon
1389
TG Therapeutics
TGTX
$8.58B
-1,562
Closed -$75K
TIMB icon
1390
TIM SA
TIMB
$10.2B
-2,491
Closed -$28K
TVTX icon
1391
Travere Therapeutics
TVTX
$5.33B
-2,293
Closed -$57K
TWST icon
1392
Twist Bioscience
TWST
$5.62B
-546
Closed -$68K
UMC icon
1393
United Microelectronic
UMC
$48.9B
-8,749
Closed -$80K
UNFI icon
1394
United Natural Foods
UNFI
$3.01B
-116,444
Closed -$3.84M
USNA icon
1395
Usana Health Sciences
USNA
$394M
-15,899
Closed -$1.55M
VCEL icon
1396
Vericel Corp
VCEL
$2.3B
-1,670
Closed -$93K
VCYT icon
1397
Veracyte
VCYT
$4.52B
-1,488
Closed -$80K
VKTX icon
1398
Viking Therapeutics
VKTX
$4.04B
-8,140
Closed -$51K
VST icon
1399
Vistra
VST
$55.1B
-170,230
Closed -$3.01M
VXRT
1400
DELISTED
Vaxart
VXRT
-11,566
Closed -$70K

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.